Author

Marion Bacou

Edinburgh Cancer Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:scATAC-seq· 1

Frequent Co-Authors

Alison M. MeynertiD· 1 shared Bradley T. HarrisiD· 1 shared Ceres Fernández–RozadillaiD· 1 shared Claire L. SmillieiD· 1 shared Edward Esiri-BloomiD· 1 shared Farhat VN DiniD· 1 shared Graeme R. GrimesiD· 1 shared Ian P.M. TomlinsoniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Alison M. MeynertORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic variation at 11q23.1 confers colorectal cancer risk by dysregulation of colonic tuft cell transcriptional activator POU2AF2

Vidya Rajasekaran, Bradley T. Harris, Ruby Tamara Osborn, Claire L. Smillie, Kevin Donnelly, Marion Bacou, Edward Esiri-Bloom, Li Yin Ooi, Morven Allan, Marion Walker, Stuart Reid, Alison M. Meynert, Graeme R. Grimes, James Peter Blackmur, Peter G Vaughan-Shaw, , Susan Mary Farrington

This study identifies rs3087967 as the causal variant at 11q23.1 that increases colorectal cancer risk by dysregulating POU2AF2, a key activator of tuft cell transcription.

Gut · Nov 28, 2024Peer-reviewedGenetics